P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

September 2005

Features

Commentary

Chronic Alert Fatigue Syndrome: An In-Your-Face Dilemma

With the proliferation of e-mail alerts, “chronic fatigue” takes on a whole new meaning.
Nancy L. Greengold, MD, MBA

Pharmaceutical Approval Update

Dr. Goldenberg discusses ramelteon (Rozerem™) for insomnia, a lidocaine–tetracaine patch (Synera™) for local dermal analgesia, and insulin detemir (Levemir®), a short-acting insulin analogue for type-1 and type-2 diabetes.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

65th Scientific Sessions of the American Diabetes Association

Some new therapies include tesaglitazar for insulin-resistant nondiabetic patients; vildagliptin, exenatide, metaglidasen, insulin glargine, pioglitazone, and rimonabant for problems associated with type-2 diabetes; inhaled insulin powder for type-1 diabetes; and pregabalin for reducing pain in diabetic peripheral neuropathy.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Continuing Education Credit

Skeletal Muscle Relaxants and Associated Medications for Nonspecific Acute Back Pain

The authors present an overview of some pharmacological and nonpharmacological modalities for treating the widespread public health problem of back pain, a major cause of disability in the U.S.
Roy R. Reeves, DO, PhD, Terrel L. Algood, RPh, and P. Melonee Wise, RPh

Departments

Editorial

Benefit Based Co-Pays: Fewer Tears

David Nash, MD, MBA, describes the concept of benefit-based co-payments, designed so that sick patients would pay less for medications than patients who use medications to prevent illness.
David Nash, MD, MBA

Medication Errors

Illusions and Medication Errors

Matthew Grissinger, RPh, FASCP, discusses ways to reduce the potential for tricks of the mind, including illusions, faulty memory, and unconscious actions, all of which can affect the performance of health care professionals.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Making Drug Ads Add up: PhRMA Voluntary Guidelines Address Clarity and Accuracy, Not Spending

Stephen Barlas explains the recent voluntary guidelines issued by PhRMA on direct-to-consumer drug advertising.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Acamprosate Calcium (Campral®): An Effective Treatment for Maintaining Abstinence in Alcohol-Dependent Patients in Combination with Psychosocial Support

Acamprosate calcium (Campral®) may help in maintaining abstinence from alcohol.
Daniela Espino, PharmD, and Martin P. Cruz, PharmD, CGP